Thumbnail Image

M. Sc. Dissertations

Browse

20071
Reset filters
Subject: Plant Pathology × Author: Sunil Kumar × End date: 2007 × Thesis Type: M.Sc ×
Reset filters

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    ThesisItemOpen Access
    Management of mungbean yellow mosaic virus in mothbean [Vigna aconitifolia (Jacq) marechal]
    (CCSHAU, 2007) Sunil Kumar; Gupta, P.P.
    Mothbean is a major commercial crop of hot arid regions of our country. It is affected by several fungal, bacterial and viral diseases. Among these mungbean yellow mosaic virus (MYMV) disease is the most important. Out of 62 genotypes screened against MYMV disease under field conditions and seventeen among them screened under green house conditions only 12 genotypes including one promising resistant check viz., RMM-47-2, RMM-44, GMO-4, RMO-257, RMB-54, CZM-90, HM-61, CZM-12, RMO-435, GMO-13, GMO-9915, CAZRI Moth-1 were found moderately resistant. Second week of June for sowing and spacing 45 cm were optimum in reducing the incidence of MYMV disease and whitefly population. The yield was also maximum (10.33 q/ha) at this conditions. There was positive correlation between disease incidence and whitefly population and yield was negatively correlated with disease incidence and whitefly population. The correlation of disease incidence with weather parameters were found non-significant. Application of phosphorus and potassium (40 kg/ha each) alone reduces the disease incidence from 47.8% (in control, no application of NPK) to 17.8% and 18.3% respectively. Highest reduction in MYMV disease incidence (70.61%), minimum whitefly population and maximum grain yield with respect to 20 kg/ha nitrogen application alone was recorded when N20P40K40 kg/ha were used. The botanical Azadirachtin (Fortune Aza, 5%) was most effective than other botanicals in reducing the MYMV disease incidence (69.43%) and increasing the grain yield (84.56%). This treatment was statistically at par with the application of Endosulfan (0.07% a.i.). Neem oil (5%) was found better next to the Azadiractin in reducing the disease incidence.